A May 2026 safety report detailed fake and gray-market GLP-1s and peptides sold online from unregistered sources. Here's a neutral verification checklist for injectables of every kind.
A May 2026 safety report described a growing gray market of counterfeit or unregistered injectables, including semaglutide, tirzepatide and experimental retatrutide, sold online and sometimes used in clinics. The protective response is unchanged: verify the provider and insist on FDA-approved product from a licensed source.
As legal access broadens and prices fall, May brought a pointed reminder that an illegal parallel market persists. A drug-safety report detailed online sellers offering substances claiming to be semaglutide, tirzepatide, and even the experimental drug retatrutide, often sourced from foreign factories not registered with the FDA, sometimes labeled "research use only," and in some cases acquired by clinics and compounders or bought directly by consumers via social media.
The risks are concrete: counterfeit or unregistered products can contain the wrong dose, no active ingredient, or contaminants, and there have been documented adverse events from fake versions purchased outside the licensed supply chain. The same dynamics that affect GLP-1s apply to aesthetic toxins, fillers, and peptides, anything sold cheaply and shipped from an unverified source.
The protective habits do not change:
Verify the provider. A licensed, trained clinician and a genuine evaluation, telehealth included.
Verify the product. FDA-approved product from authorized distributors or licensed pharmacies; be wary of social-media sales, prices that seem too good to be true, unfamiliar packaging, and "research use only" labels.
WHY IT MATTERS This is the core reason a verification-focused directory exists. The single most protective move a consumer can make is to refuse products from unverified online sources and to confirm both the injector and the product before any treatment. Report suspected counterfeits or adverse events to the FDA's MedWatch program, and buy prescription products only from state-licensed pharmacies.